Fischer Medical Ventures Limited (BOM:524743)

Fischer Medical Ventures Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	24,605	26,207	57,275	33,419	14	13
Market Cap Growth	-63.44%	-54.24%	71.39%	231203.81%	7.62%	206.08%
Enterprise Value	25,443	26,154	57,247	33,399	19	16
Last Close Price	37.94	40.41	89.77	62.47	8.40	7.80

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	89.31	83.88	4741.67	1818.31	-	-
PS Ratio	6.70	8.49	51.74	159.28	8.05	-
PB Ratio	6.36	6.78	16.95	41.20	-5.43	-5.85
P/TBV Ratio	6.51	6.93	17.24	42.36	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	6.93	8.48	51.71	159.18	10.53	-
EV/EBITDA Ratio	52.32	64.16	2416.61	1888.98	-	-
EV/EBIT Ratio	54.40	65.22	3346.01	1990.88	123.50	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.28	0.28	0.25	0.02	-2.15	-1.70
Debt / EBITDA Ratio	2.52	2.63	33.94	0.90	-	-
Net Debt / Equity Ratio	0.21	0.21	-0.49	-0.45	-2.01	-1.63
Net Debt / EBITDA Ratio	1.93	2.01	-70.07	-20.51	-	-
Net Debt / FCF Ratio	-	-	1.79	4.63	-3.67	-2.11
Asset Turnover	-	0.55	0.41	0.48	0.66	-
Inventory Turnover	-	17.92	13.46	-	-	-
Quick Ratio	-	1.22	3.24	15.97	4.32	0.04
Current Ratio	-	1.60	3.59	18.37	5.19	0.12
Return on Equity (ROE)	-	8.63%	0.58%	4.55%	-	-
Return on Assets (ROA)	-	4.44%	0.39%	2.42%	3.52%	-53.14%
Return on Invested Capital (ROIC)	5.90%	8.40%	0.86%	6.47%	40.16%	-
Return on Capital Employed (ROCE)	-	9.70%	0.50%	2.00%	5.00%	82.20%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 20, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.23%	1.19%	0.02%	0.06%	-2.53%	-17.33%
FCF Yield	-	-	-1.62%	-0.24%	-10.10%	-13.18%
Dividend Yield	0.13%	0.12%	0.01%	-	-	-
Buyback Yield / Dilution	-	-26.45%	-223.98%	-9752.91%	-	-
Total Shareholder Return	0.13%	-26.32%	-223.97%	-9752.91%	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error